英格兰儿童和青少年SARS-CoV-2感染相关住院的队列研究:320万例首次确诊感染
该队列研究利用英格兰电子健康记录数据,纳入2020年7月至2022年2月约1200万18岁以下儿童青少年中3 226 535例首次确诊SARS-CoV-2感染者,描述其相关住院情况。结果显示29 230例(0.9%)感染发生SARS-CoV-2相关住院,中位住院2天(IQR 1-4),1710例(5.9%)入住儿科重症监护;SARS-CoV-2为病因或促进因素者21 000例(71.8%),院内感染仅380例(1.3%), incidental感染7855例(26.9%)。男童、5岁以下儿童、少数族裔或高剥夺地区人群更易住院(均P<0.001)。结论认为多数儿童青少年SARS-CoV-2相关住院由SARS-CoV-2所致或为其促进因素,应据此指导未来公共卫生举措和研究。
要点
- 3 226 535例儿童青少年首次SARS-CoV-2感染中29 230例(0.9%)发生SARS-CoV-2相关住院。
- 住院者中SARS-CoV-2为病因或促进因素者21 000例(71.8%),院内感染仅380例(1.3%), incidental感染7855例(26.9%)。
- 29 230例相关住院中1710例(5.9%)涉及儿科重症监护,中位住院时间2天(IQR 1-4)。
- 男童、5岁以下儿童、少数族裔或高剥夺地区人群住院风险更高(均P<0.001)。
- 住院者中11 085例(37.9%)存在英格兰新冠疫苗接种规划所列高风险疾病,另有4765例(16.3%)存在未列入该清单的医学或发育健康状况。
适用人群与场景
- 英格兰居民,年龄<18岁的儿童和青少年,约1200万人。
- 研究期间(2020年7月至2022年2月)记录到首次确诊SARS-CoV-2感染者共3 226 535例。
诊断标准与关键阈值
- 首次SARS-CoV-2相关住院分为:因SARS-CoV-2所致、SARS-CoV-2为促进因素、 incidental于SARS-CoV-2感染、院内获得SARS-CoV-2。
研究设计与关键结果
- 研究类型:基于电子健康记录数据的队列研究;人群:英格兰约1200万<18岁儿童青少年中3 226 535例首次确诊SARS-CoV-2感染者;观察期2020年7月至2022年2月。
- 29 230例(0.9%)感染发生SARS-CoV-2相关住院;中位住院时间2天(IQR 1-4天);1710/29 230例(5.9%)涉及儿科重症监护。
- SARS-CoV-2为病因或促进因素者21 000/29 230例(71.8%);院内获得感染380例(1.3%); incidental感染7855例(26.9%)。
- 70例死亡以COVID-19或儿科炎症多系统综合征为列明死因,其中55例(78.6%)发生在有SARS-CoV-2相关住院的参与者中。
- 男童、<5岁儿童、少数族裔或高剥夺地区人群更可能住院(均P<0.001)。
- 住院者中11 085例(37.9%)存在英格兰新冠疫苗接种规划所列高风险疾病,另有4765例(16.3%)存在未列入该清单的医学或发育健康状况。
证据类型、等级与局限
- 证据类型:队列研究(基于电子健康记录数据)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,英格兰儿童和青少年中大多数SARS-CoV-2相关住院由SARS-CoV-2所致或为其促进因素,这些结果应有助于指导未来公共卫生举措和研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To describe hospital admissions associated with SARS-CoV-2 infection in children and adolescents.
DESIGN: Cohort study of 3.2 million first ascertained SARS-CoV-2 infections using electronic health care record data.
SETTING: England, July 2020 to February 2022.
PARTICIPANTS: About 12 million children and adolescents (age <18 years) who were resident in England.
MAIN OUTCOME MEASURES: Ascertainment of a first SARS-CoV-2 associated hospital admissions: due to SARS-CoV-2, with SARS-CoV-2 as a contributory factor, incidental to SARS-CoV-2 infection, and hospital acquired SARS-CoV-2.
RESULTS: 3 226 535 children and adolescents had a recorded first SARS-CoV-2 infection during the observation period, and 29 230 (0.9%) infections involved a SARS-CoV-2 associated hospital admission. The median length of stay was 2 (interquartile range 1-4) days) and 1710 of 29 230 (5.9%) SARS-CoV-2 associated admissions involved paediatric critical care. 70 deaths occurred in which covid-19 or paediatric inflammatory multisystem syndrome was listed as a cause, of which 55 (78.6%) were in participants with a SARS-CoV-2 associated hospital admission. SARS-CoV-2 was the cause or a contributory factor in 21 000 of 29 230 (71.8%) participants who were admitted to hospital and only 380 (1.3%) participants acquired infection as an inpatient and 7855 (26.9%) participants were admitted with incidental SARS-CoV-2 infection. Boys, younger children (<5 years), and those from ethnic minority groups or areas of high deprivation were more likely to be admitted to hospital (all P<0.001). The covid-19 vaccination programme in England has identified certain conditions as representing a higher risk of admission to hospital with SARS-CoV-2: 11 085 (37.9%) of participants admitted to hospital had evidence of such a condition, and a further 4765 (16.3%) of participants admitted to hospital had a medical or developmental health condition not included in the vaccination programme's list.
CONCLUSIONS: Most SARS-CoV-2 associated hospital admissions in children and adolescents in England were due to SARS-CoV-2 or SARS-CoV-2 was a contributory factor. These results should inform future public health initiatives and research.
参考来源
- Wilde H, Tomlinson C, Mateen BA, et al. Hospital admissions linked to SARS-CoV-2 infection in children and adolescents: cohort study of 3.2 million first ascertained infections in England. BMJ. 2023. PMID: 37407076. doi:10.1136/bmj-2022-073639
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。